128 related articles for article (PubMed ID: 22815650)
1. Fast, slow, or not at all: the extracellular matrix controls movement of signaling molecules.
Robinson R
PLoS Biol; 2012 Jul; 10(7):e1001362. PubMed ID: 22815650
[No Abstract] [Full Text] [Related]
2. Internalization of basic fibroblast growth factor by CCL39 fibroblast cells. Involvement of heparan sulfate glycosaminoglycans.
Gannoun-Zaki L; Pieri I; Badet J; Moenner M; Barritault D
Ann N Y Acad Sci; 1991; 638():431-3. PubMed ID: 1785816
[No Abstract] [Full Text] [Related]
3. Minimal sequence in heparin/heparan sulfate required for binding of basic fibroblast growth factor.
Maccarana M; Casu B; Lindahl U
J Biol Chem; 1994 Feb; 269(5):3903. PubMed ID: 8106436
[No Abstract] [Full Text] [Related]
4. Transport of fibroblast growth factor 2 in the pericellular matrix is controlled by the spatial distribution of its binding sites in heparan sulfate.
Duchesne L; Octeau V; Bearon RN; Beckett A; Prior IA; Lounis B; Fernig DG
PLoS Biol; 2012 Jul; 10(7):e1001361. PubMed ID: 22815649
[TBL] [Abstract][Full Text] [Related]
5. Heparan sulfate alterations in extracellular matrix structures and fibroblast growth factor-2 signaling impairment in the aged neurogenic niche.
Yamada T; Kerever A; Yoshimura Y; Suzuki Y; Nonaka R; Higashi K; Toida T; Mercier F; Arikawa-Hirasawa E
J Neurochem; 2017 Aug; 142(4):534-544. PubMed ID: 28547849
[TBL] [Abstract][Full Text] [Related]
6. A dual receptor system is required for basic fibroblast growth factor activity.
Klagsbrun M; Baird A
Cell; 1991 Oct; 67(2):229-31. PubMed ID: 1655276
[No Abstract] [Full Text] [Related]
7. Heparan sulphate proteoglycans and diabetic nephropathy.
van der Woude FJ; van Det NF
Exp Nephrol; 1997; 5(3):180-8. PubMed ID: 9208276
[No Abstract] [Full Text] [Related]
8. Sequestration and release of basic fibroblast growth factor.
Vlodavsky I; Bashkin P; Ishai-Michaeli R; Chajek-Shaul T; Bar-Shavit R; Haimovitz-Friedman A; Klagsbrun M; Fuks Z
Ann N Y Acad Sci; 1991; 638():207-20. PubMed ID: 1664685
[No Abstract] [Full Text] [Related]
9. Basic fibroblast growth factor binds to heparan sulfate in the extracellular matrix of rat growth plate chondrocytes.
Chintala SK; Miller RR; McDevitt CA
Arch Biochem Biophys; 1994 Apr; 310(1):180-6. PubMed ID: 8161203
[TBL] [Abstract][Full Text] [Related]
10. [Biosynthesis of the bFGF binding domains of heparan sulfate-N-deacetylase/N-sulfotransferase].
Ishihara M
Seikagaku; 1993 Dec; 65(12):1512-6. PubMed ID: 8308396
[No Abstract] [Full Text] [Related]
11. Platelet Factor 4 Binds to Vascular Proteoglycans and Controls Both Growth Factor Activities and Platelet Activation.
Lord MS; Cheng B; Farrugia BL; McCarthy S; Whitelock JM
J Biol Chem; 2017 Mar; 292(10):4054-4063. PubMed ID: 28115521
[TBL] [Abstract][Full Text] [Related]
12. Interactions that influence the binding of synthetic heparan sulfate based disaccharides to fibroblast growth factor-2.
Li YC; Ho IH; Ku CC; Zhong YQ; Hu YP; Chen ZG; Chen CY; Lin WC; Zulueta MM; Hung SC; Lin MG; Wang CC; Hsiao CD
ACS Chem Biol; 2014 Aug; 9(8):1712-7. PubMed ID: 24959968
[TBL] [Abstract][Full Text] [Related]
13. Heparan sulfate proteoglycans in the human sclerosing and scarring kidney. Changes in heparan sulfate moiety.
Morita H; David G; Mizutani A; Shinzato T; Habuchi H; Maeda K; Kimata K
Contrib Nephrol; 1994; 107():174-9. PubMed ID: 8004965
[No Abstract] [Full Text] [Related]
14. Interaction of heparan sulfate from mammary cells with acidic fibroblast growth factor (FGF) and basic FGF. Regulation of the activity of basic FGF by high and low affinity binding sites in heparan sulfate.
Rahmoune H; Chen HL; Gallagher JT; Rudland PS; Fernig DG
J Biol Chem; 1998 Mar; 273(13):7303-10. PubMed ID: 9516424
[TBL] [Abstract][Full Text] [Related]
15. Differential binding of fibroblast growth factor-2 and -7 to basement membrane heparan sulfate: comparison of normal and abnormal human tissues.
Friedl A; Chang Z; Tierney A; Rapraeger AC
Am J Pathol; 1997 Apr; 150(4):1443-55. PubMed ID: 9094999
[TBL] [Abstract][Full Text] [Related]
16. Heparan sulphate and protein recognition. Binding specificities and activation mechanisms.
Gallagher JT
Adv Exp Med Biol; 1995; 376():125-34. PubMed ID: 8597238
[No Abstract] [Full Text] [Related]
17. Minimal sequence in heparin/heparan sulfate required for binding of basic fibroblast growth factor.
Maccarana M; Casu B; Lindahl U
J Biol Chem; 1993 Nov; 268(32):23898-905. PubMed ID: 8226930
[TBL] [Abstract][Full Text] [Related]
18. Heparan sulfate proteoglycans function as receptors for fibroblast growth factor-2 activation of extracellular signal-regulated kinases 1 and 2.
Chua CC; Rahimi N; Forsten-Williams K; Nugent MA
Circ Res; 2004 Feb; 94(3):316-23. PubMed ID: 14684627
[TBL] [Abstract][Full Text] [Related]
19. Antagonising angiogenesis in rheumatoid arthritis.
Brenchley PE
Ann Rheum Dis; 2001 Nov; 60 Suppl 3(Suppl 3):iii71-4. PubMed ID: 11890660
[No Abstract] [Full Text] [Related]
20. Animal cell mutants defective in heparan sulfate polymerization.
Esko JD
Adv Exp Med Biol; 1992; 313():97-106. PubMed ID: 1442273
[No Abstract] [Full Text] [Related]
[Next] [New Search]
